510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K011710Substantially Equivalent

Oxoid Pbp2 1 Latex Agglutination Test

Oxoid, Ltd., Basingstoke, GB / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)

K011710 is the FDA 510(k) clearance record for OXOID PBP2 1 LATEX AGGLUTINATION TEST, a class II device, cleared for Oxoid , Ltd. on under FDA product code MYI (System, Test, Genotypic Detection, Resistant Markers, Staphylococcus Colonies). FDA records list 36 510(k) clearances for Oxoid , Ltd., from to . As of , FDA records show no recalls naming K011710.

Clearance record

Decision date
Received
(302 days to decision)
Product code
MYI System, Test, Genotypic Detection, Resistant Markers, Staphylococcus Colonies
Regulation
21 CFR 866.1640
Device class
Class II
Review panel
Microbiology
Applicant
Oxoid , Ltd. Wade Rd., Basingstoke, GB
510(k) summary
Statement
Third party review
No

Clearances, product code MYI

Trailing 12 months

FDA records hold no clearances under product code MYI in the trailing twelve months.

FDA records show no clearances under product code MYI in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code MYI, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260